From October 13 to 16, 2022, the Company accepted and passed the patrol inspection (pharmacovigilance involved) on Tetanus Vaccine, Adsorbed by the inspection team organized by the National Vaccine Inspection Center.

From October 27 to 28, 2022, the Company accepted and passed the on-site pharmacovigilance inspection by the inspection team organized by Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring.

The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.